大型远程重症监护项目实施与死亡率及住院时间关联分析
该回顾性研究分析了2015年1月1日至2024年4月30日期间北加州整合医疗系统18个内外科病房的成人ICU患者,比较远程重症监护(TCC)项目实施前后共172,878例次住院(TCC前137,457例,TCC后35,421例)。未调整分析中TCC暴露组住院死亡率更高(17.8% vs 14.3%),但调整人口学、病情急重度和合并症后,TCC暴露与住院死亡率降低相关(ARR 0.93,95%CI 0.89-0.98)。死亡率调整后的ICU住院时间差异为-0.07天(95%CI -0.18至0.05天),住院时间差异为-0.10天(95%CI -0.35至0.15天),均无统计学显著性。研究表明多医院夜间TCC覆盖可能降低调整后住院死亡风险,但未观察到住院时间的显著改善。
要点
- 调整混杂因素后,TCC暴露与住院死亡率降低相关:ARR 0.93(95%CI 0.89-0.98)。
- 未调整分析中TCC暴露组死亡率反而更高(17.8% vs 14.3%),提示存在病情严重程度等混杂。
- 死亡率调整后ICU住院时间差异为-0.07天(95%CI -0.18至0.05天),无统计学显著性。
- 死亡率调整后住院时间差异为-0.10天(95%CI -0.35至0.15天),无统计学显著性。
- 研究纳入18个内外科病房,TCC项目为夜间覆盖模式。
适用人群与场景
- 2015年1月1日至2024年4月30日期间在北加州整合医疗系统18个内外科病房住院的成人ICU患者,共172,878例次(TCC前137,457例,TCC后35,421例)。
研究设计与关键结果
- 研究类型:回顾性研究,比较TCC项目实施前后成人ICU患者的住院死亡率和住院时间。
- 样本量:172,878例次患者 encounters(TCC前137,457例,TCC后35,421例),来自18个内外科病房。
- 未调整分析:TCC暴露组住院死亡率17.8%,非TCC组14.3%;TCC组平均病情急重度指数、COVID-19发生率和机械通气率更高,但入院时平均合并症评分版本2更低。
- 主要终点:调整人口学、病情急重度和合并症后,TCC暴露与住院死亡率降低相关,ARR 0.93(95%CI 0.89-0.98)。
- 关键次要终点:死亡率调整后ICU住院时间差异-0.07天(95%CI -0.18至0.05天),住院时间差异-0.10天(95%CI -0.35至0.15天),均无统计学显著性。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论指出,多医院实施夜间TCC项目与调整后住院死亡率风险降低相关,但死亡率调整后ICU或住院时间无显著差异。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Multiple studies of telecritical care (TCC) programs have demonstrated an association between TCC implementation and reduced mortality, as well as decreased hospital and ICU length of stay (LOS), but these effects have been heterogeneous. We evaluated the impact of implementing a TCC program on inpatient mortality and LOS and examined heterogeneity in outcomes by acute severity of illness and chronic comorbidity groups.
DESIGN: Retrospective study of adult ICU patients with and without TCC program exposure between January 1, 2015, and April 30, 2024.
SETTING: Eighteen medical surgical units in an integrated healthcare system in Northern California before and after implementation of an overnight TCC program.
PATIENTS: A total of 172,878 patient encounters (137,457 pre-TCC and 35,421 post-TCC implementation).
INTERVENTIONS: No intervention.
MEASUREMENTS AND MAIN RESULTS: We used generalized linear models to estimate adjusted relative risk (ARR) of inpatient mortality and differences in hospital and ICU LOS comparing TCC exposed and unexposed groups. We performed mortality-adjusted LOS analysis by setting decedents' LOS to the 99th percentile of non-TCC encounters' LOS. Unadjusted analyses showed that the TCC exposed group had higher inpatient mortality (17.8 vs. 14.3% TCC vs. non-TCC), mean acuity indices, rates of COVID-19, and mechanical ventilation despite lower mean Comorbidity Point Score, Version 2, at admission. After adjustment for patient demographics, acuity, and comorbidity, TCC exposure was associated with decreased inpatient mortality with an ARR of 0.93 (95% CI, 0.89-0.98). The mortality-adjusted ICU and hospital LOS were not statistically significant in the TCC exposed group, with a difference of -0.07 days ICU LOS (95% CI, -0.18 to 0.05 d) and -0.10 days hospital LOS (95% CI, -0.35 to 0.15 d).
CONCLUSIONS: Multihospital implementation of night coverage by a TCC program was associated with a reduced adjusted risk of inpatient mortality with no significant differences in mortality-adjusted ICU or hospital LOS.
参考来源
- Guarnieri M, Kipnis P, Panchal A, et al. Analysis of Mortality and Length of Stay Associated With Implementation of a Large Telecritical Care Program in an Integrated Healthcare System. Crit Care Med. 2025. PMID: 41165406. doi:10.1097/CCM.0000000000006914
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。